PHASQ
PhaseBio Pharmaceuticals, Inc.
OTCHealthcareBiotechnologyUS
Company Profile
CEO
Jonathan P. Mow MBA
IPO Date
2018-10-18
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
PhaseBio Pharmaceuticals, Inc.
CEO
Jonathan P. Mow MBA
IPO Date
2018-10-18
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| $0.00 |
| 19 May 2023 | Humphries William D. | director | M-Exempt | Acquired | 2,538 | $0.00 |
| 19 May 2023 | Humphries William D. | director | M-Exempt | Disposed | 2,538 | $0.00 |
| 19 May 2023 | Hutson Nancy J | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | Hutson Nancy J | director | M-Exempt | Disposed | 3,750 | $0.00 |
| 19 May 2023 | HARRIGAN EDMUND | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | HARRIGAN EDMUND | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | Loewy Caroline M | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | Loewy Caroline M | director | M-Exempt | Disposed | 3,750 | $0.00 |